Sage, Biogen

Sage rejects Biogen's $469 million takeover offer, says offer undervalues company
Sage Therapeutics said on Monday that its board has unanimously rejected Biogen’s $469 million offer, stating it "significantly undervalues" the company and does not serve shareholders' best interests.
Sage rebuffs Biogen bid to take it over
Sage’s board of directors said Biogen’s offer “undervalues” the company, but will explore other strategic alternatives to “maximize” shareholder value.
Sage rejects Biogen’s buyout offer, but says it's open to deals
Sage Therapeutics has rejected the unsolicited acquisition offer it received earlier this month from longtime partner Biogen Inc.
Sage rejects Biogen's $469 million takeover offer
Sage Therapeutics said on Monday that its board has unanimously rejected the takeover offer it received from Biogen. The company said Biogen's offer to buy all outstanding shares of Sage that it does not already own for $7.
No deal: Sage rejects Biogen's buyout offer, scouts for strategic alternatives
After receiving and considering an "unsolicited" buyout offer from partner Biogen, Sage Therapeutics is kicking the tires on a range of strategic options. | The company's board of directors unanimously rejected partner Biogen's $469 million buyout proposal,
Sage Rejects Biogen’s Unsolicited Offer, Will Seek Strategic Alternatives
Following a lawsuit filed last week, Sage has officially rejected Biogen’s unsolicited buyout offer, which valued the embattled biotech at just $469 million.
Sage Therapeutics Explores Alternatives, Rejects Biogen's Proposal, Stock Up
The proposal sought to acquire all outstanding shares of Sage not already owned by Biogen for $7.22 per share, a valuation deemed insufficient by the Board. Meanwhile, Sage remains committed to its mission of making ZURZUVAE the standard treatment for women with postpartum depression as the Board evaluates potential strategic opportunities.
Sage Rejects Biogen Bid, Launches Review of Alternatives
Sage Therapeutics has rejected a buyout bid from partner Biogen and launched a review of strategic alternatives. Sage on Monday said its board determined that Biogen's $7.22-a-share proposal significantly undervalues the biopharmaceutical company and isn't in the best interest of its shareholders.
Sage Therapeutics rejects Biogen bid, starts strategic review
Sage Therapeutics rejected a takeover offer from Biogen (BIIB) and said it started a process to review its strategic alternatives. Sage rose 5.6%. Sage's board will look at a range of opportunities, including a potential strategic transaction,
Pierre Sage sacked as Lyon manager, Paulo Fonseca favourite to succeed
According to a report from L’Équipe, Olympique Lyonnais have decided to sack Pierre Sage from his role as manager following ...
Sage Group falls Monday, underperforms market
Sage Group PLC SGE shares inched down 0.34% to £13.26 Monday, on what proved to be an all-around favorable trading session ...
‘Recalibrated’ Sage Hill girls basketball races past Portola to extend winning streak
Amalia Holguin, Addison Uphoff and Kamdyn Klamberg combine for 47 points as Sage Hill wins its sixth straight game.
Interview with Travis Barton, founder of 'pocket park' honoring Sage Lindsay
Former Bozeman Fire union president and welder Travis Barton established a small park in Sage Lindsay's honor and has left ...
Sage Group falls Friday, still outperforms market
Sage Group PLC SGE shares inched down 0.49% to £13.30 Friday, on what proved to be an all-around poor trading session for the ...
NCIS: Origins' Austin Stowell Talks Gibbs' Rules And Reveals The Real-Life Rule He Learned From 'Sage' Mark Harmon
Origins has been taking fans back to the ‘90s pre-NCIS to follow a young Leroy Jethro Gibbs, played by Austin Stowell. The ...
TaxBandits Strengthens Its Partnership with Sage Intacct for Another Successful Season of 1099 E-filing
ROCK HILL, SC / ACCESS Newswire / January 27, 2025 / With the January 31, 2025, deadline for 1099 filing approaching, TaxBandits, an authorized ...
TheGamer on MSN4d
Guide To Playing Sage In PvP In FFXIV
While you don't have all the multitude of skills Sage has in PvE, the core concept of the job is maintained in PvP. Although ...